Cyanotech (CYAN) reported a loss of $0.12 per share in its first quarter. The company reported revenue of $7.3 million, down 3.9% on a year-over-year basis.

Moleculin Biotech (MBRX) reported a loss of $0.11 per share in its second quarter. The company ended the quarter with $7.2 million in cash and cash equivalents on its balance sheet.

Syros Pharmaceuticals (SYRS) reported a loss of $5.42 per share in its second quarter. The company ended the quarter with $50.1 million in cash and cash equivalents on its balance sheet.

Celsion (CLSN) reported a loss of $0.19 per share in its second quarter, beating consensus forecast by $0.05 million.

Cerecor (CERC) reported a loss of $0.41 per share in its second quarter. The company reported revenue of $0.65 million.